Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

• Main Authors: Chanhee Han (Author), Stefania Bellone (Author), Peter E. Schwartz (Author), Serengulam V. Govindan (Author), Robert M. Sharkey (Author), David M. Goldenberg (Author), Alessandro D. Santin (Author)
• Formato: Libro
• Publicado: Elsevier, 2018-08-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited. Case: We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease, who experie...